| ||
| Synta Announces Ganetespib Phase 2 Non-small Cell Lung Cancer ... {Businesswire via BioPortfolio} Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today presented results at the Annual Meeting of the American Society for ... www.bioportfolio.com/.../Synta-Announces-Ganetespib-Phase... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment